US Patent:
20080045586, Feb 21, 2008
Inventors:
Anne MINNICH - Flemington NJ, US
Theresa KUNTZWEILER - Bernardsville NJ, US
Haifeng EISHINGDRELO - Montville NJ, US
Michael ANGELASTRO - Bridgewater NJ, US
Stephan HENKE - Tucson AZ, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
A61K 31/35
A61P 29/00
Abstract:
Host cells expressing HM74 were used to obtain oxydecalin-like molecules with agonist activity having the following structure: